01 3Orfadin
Main Therapeutic Indication : Genetic Disorders
Currency : USD
2021 Revenue in Millions : 49
2020 Revenue in Millions : 73
Growth (%) : -31
Main Therapeutic Indication : Genetic Diseases
Currency : USD
2022 Revenue in Millions : 44
2021 Revenue in Millions : 49
Growth (%) : -12
Main Therapeutic Indication : Genetic Diseases
Currency : USD
2023 Revenue in Millions : 43
2022 Revenue in Millions : 44
Growth (%) : -2
LOOKING FOR A SUPPLIER?